Page 2 - Best Glioma doctors: TOP 67 doctors

A top neurosurgeon worldwide, Prof. Zvi Ram leads the European Association of Neurosurgical Societies and provides innovative glioma care at Sourasky Medical Center.

• Expert in complex brain tumor surgery with brain mapping and deep brain stimulation
• Highly trained in microsurgical and image-guided techniques for brain tumors
• Conducts leading research on gene-based therapies for brain cancer
• Recognized with the Goldhirsh Foundation Award for innovative neurology treatments

Dr. Yildiz has over a decade of specialist oncology experience, focusing on advanced cancer cases at Medipol Mega University Hospital.

• Over 76 years of experience of experience in medical oncology
• Holds a professorship in oncology – an expert who trains other doctors
• Published extensively in international medical journals on various cancers
• Member of the European Society for Medical Oncology (ESMO)
• Special interest in neuroendocrine tumors and complex case management

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in glioma treatment, specializing in targeted therapies and individualized cancer medicine at Wiener Privatklinik.

• Over 22 years of experience of experience in medical oncology
• Focuses on biomarker development and tumor biology
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Published extensively in leading international journals

Phd Viola Fox heads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen, with over 14 years of experience of specialized experience in glioma and other tumor treatments.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified in genetics, enhancing personalized treatment approaches
• Active in molecular biology research for innovative cancer therapies
• Member of German and American oncology societies

Professor Keil specializes in advanced imaging techniques for glioma, with expertise in diagnostic and interventional radiology at Academic Hospital Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Over 22 years of experience of experience in radiology, including MRI and CT diagnostics
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for complex medical interventions

Specializes in virotherapy – one of the newest immunology fields – with 49 years of experience of experience at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute
• Internship in Internal Medicine

Dr. Alemdar specializes in Medical Oncology with extensive training at Akdeniz University – a leader in oncology care.

• Board-certified in Medical Oncology since 2018
• Over 20 years of experience of experience in oncology
• Works at Medical Park Antalya Hospital Complex

Assoc. Prof. Nail Paksoy is a medical oncologist specializing in glioma treatment at Medipol Bahçelievler Hospital, with ESMO Board Certification and extensive research experience.

• Fellowship-trained at Istanbul University Oncology Institute
• Participated in 8 international clinical trials for cancer treatments
• Published multiple studies on brain tumors and neuro-oncology
• ESMO Board Certified in Medical Oncology

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Pioneer in defining strict criteria for paraneoplastic neurological syndromes – Dr. Graus is a leading figure in neuro-oncology at Hospital Quiron Barcelona.

• Former Chief of Neurology at Hospital Clinic, Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Trained in neuro-oncology at Memorial Sloan-Kettering Cancer Center
• Honored with Doctor Honoris Causa by Lyon University